Chimeric aptamers in cancer cell-targeted drug delivery

References

• Alaoui AT et al. 2002. High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands. Nucl Acids Res 30:45–49.
   Google Scholar
• Alonso MJ, Gupta RK, Min C, Siber GR, Langer R. 1994. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 12:299–306.
   PubMed Web of Science ®Google Scholar
• Altieri DC. 2003. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22:8581–8589.
   PubMed Web of Science ®Google Scholar
• Baratchi S, Kanwar RK, Kanwar JR. 2010. Survivin: A target from brain cancer to neurodegenerative disease. Crit Rev Biochem Mol Biol 45:535–554.
   PubMed Web of Science ®Google Scholar
• Barciszewski J, Medgaard M, Koch T, Kurreck J, Erdmann VA. 2009. Locked nucleic acid aptamers. Methods Mol Biol 535:165–186.
   Google Scholar
• Barry P, Robert JD, Gold L. 1996. High affinity nucleic acid ligands that discriminate between theophylline and caffeine. US Patent No 5, 580,737.
   Google Scholar
• Bassett SE, Fennewald SM, King DJ, Li X, Herzog NK, Shope R, Aronson JF, Luxon BA, Gorenstein DG. 2004. Combinatorial selection and edited combinatorial selection of phosphorothioate aptamers targeting human nuclear factor-kappaB RelA/p50 and RelA/RelA. Biochemistry 43:9105–9115.
   PubMed Web of Science ®Google Scholar
• Becker RC, Chan MY. 2009. REG-1, a regimen comprising RB-006, a Factor IXa antagonist, and its oligonucleotide active control agent RB-007 for the potential treatment of arterial thrombosis. Curr Opin Mol Ther 11:707–715.
   PubMed Web of Science ®Google Scholar
• Berezovski M, Krylov SN. 2004. Using nonequilibrium capillary electrophoresis of equilibrium mixtures for the determination of temperature in capillary electrophoresis. Anal Chem 76:7114–7117.
   PubMed Web of Science ®Google Scholar
• Bivalkar-Mehla Svj Mehla, R, Abreha M, Kanwar JR, Tikoo A, Chauhan A. 2010. Viral Rna silencing suppressors (Rss): Novel strategy of viruses to ablate the host Rna interference (Rnai) defense system. Virus Res 155:1–9.
   Google Scholar
• Bruno JG, Kiel JL. 2002. Use of magnetic beads in selection and detection of biotoxin aptamers by electrochemiluminescence and enzymatic methods. BioTechniques 32:178–80–182.
   Google Scholar
• Burke DH, Gold L. 1997a. RNA aptamers to the adenosine moiety of S-adenosyl methionine: Structural inferences from variations on a theme and the reproducibility of SELEX. Nucleic Acids Res 25:2020–2024.
   Google Scholar
• Burke DH, Hoffman DC, Brown A, Hansen M, Pardi A, Gold L. 1997b. RNA aptamers to the peptidyl transferase inhibitor chloramphenicol. Chem Biol 4:833–843.
   PubMed Web of Science ®Google Scholar
• Burke DH, Willis JH. 1998. Recombination, RNA evolution, and bifunctional RNA molecules isolated through chimeric SELEX. RNA 4:1165–1175.
   PubMed Web of Science ®Google Scholar
• Cheng, C, Li, LM. 2008. Inferring MicroRNA activities by combining gene expression with MicroRNA target prediction. Plos One 3:1–9.
   Google Scholar
• Corgentech Inc (2004, 07 Dec). From Edifoligide (E2F Decoy) Phase 3 Trial For Peripheral Bypass Graft. http://www.medicalnewstoday.com/articles/17439.php.
   Google Scholar
• Cai H, Reinisch K, Ferro-Novick S. 2007. Coats, tethers, Rabs, and SNAREs work together to mediate the intracellular destination of a transport vesicle. Dev Cell 12:671–682.
   PubMed Web of Science ®Google Scholar
• Cancerhelp.,Org.UK (2010). A trial of LY2181308 alongside chemotherapy for non small cell lung cancer. http://www.cancerhelp.org.uk/trials/a-trial-of-ly2181308-alongside-chemotherapy-for-non-small-cell-lung-cancer
   Google Scholar
• Carlton J, Bujny M, Rutherford A, Cullen P. 2005. Sorting nexins–unifying trends and new perspectives. Traffic 6:75–82.
   PubMed Web of Science ®Google Scholar
• Carrasquillo KG, Ricker JA, Rigas IK, Miller JW, Gragoudas ES, Adamis AP. 2003. Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres. Invest Ophthalmol Vis Sci 44:290–299.
   PubMed Web of Science ®Google Scholar
• Centi S, Tombelli S, Palchetti I. & Mascini M. 2010. Development of an aptamer-based electrochemical sandwich assay for the detection of a clinical biomarker. Sensors and Lecture Notes in Electrical Engineering 54:207–210.
   Google Scholar
• Chávez JL, Lyon W, Kelley-Loughnane N, Stone MO. 2010. Theophylline detection using an aptamer and DNA-gold nanoparticle conjugates. Biosens Bioelectron 26:23–28.
   Google Scholar
• Chen Z, Li G, Zhang L, Jiang J, Li Z, Peng Z, Deng L. 2008. A new method for the detection of ATP using a quantum-dot-tagged aptamer. Anal Bioanal Chem 392:1185–1188.
   PubMed Web of Science ®Google Scholar
• Cheung CH, Sun X, Kanwar JR, Bai JZ, Cheng L, Krissansen GW. 2010. A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-a therapy. Cancer Cell Int 10:36.
   PubMedGoogle Scholar
• Chi-Hong B, Chen KRD, Christopher PO, Cecilia DS, Meikana L, George AC, Michelle G, Francis EB, Audrey LF, Rachel M, Elizabeth FN. 2008. Aptamer-based endocytosis of a lysosomal enzyme. Proc Natl Acad Sci USA 105:15908–15913.
   Google Scholar
• Clinicaltrials.,Gov. 2010. A Study of Arc1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration. http://clinicaltrials.gov/show/Nct00950638
   Google Scholar
• Clinicaltrials.,Gov. 2009. Arc1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders. http://clinicaltrialsfeeds.org/clinical-trials/show/Nct00632242
   Google Scholar
• Collett JR, Cho EJ, Ellington AD. 2005. Production and processing of aptamer microarrays. Methods 37:4–15.
   PubMed Web of Science ®Google Scholar
• DI Primo C et al. 2007. Systematic screening of Lna/20-O-methyl chimeric derivatives of a Tar Rna aptamer. Febs Letters 581:771–774.
   Google Scholar
• Ducongé F, Toulmé JJ. 1999. In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1. RNA 5:1605–1614.
   PubMed Web of Science ®Google Scholar
• Eckstein F, Gish G. 1989. Phosphorothioates in molecular biology. Trends Biochem Sci 14:97–100.
   PubMed Web of Science ®Google Scholar
• Eli G. 2010. Aptamer-targeted sirna to prevent attenuation or suppression of a T cell function. United States patent application, 12/752,802.
   Google Scholar
• Ellington, AD, Szostak, JW. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346,818–822.
   PubMed Web of Science ®Google Scholar
• Ellington ADS, Szostak W. 1992. Selection in vitro of single-stranded Dna molecules that fold into specific ligand-binding structures. Nature 355:850–852.
   PubMed Web of Science ®Google Scholar
• Enomoto, L, Anderson, PL, Li, S, Edelstein, CL, Weinber, GA. 2011. Effect of Nucleoside and Nucleotide Analog Reverse Transcriptase Inhibitors on Cell-Mediated Immune Functions. AIDS Research and Human Retroviruses 27:47–55.
   PubMed Web of Science ®Google Scholar
• Eulberg D, Klussmann S. 2003. Spiegelmers: Biostable aptamers. Chembiochem 4:979–983.
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Jon S, Khademhosseini A, Tran TN, Lavan DA, Langer R. 2004. Nanoparticle-aptamer bioconjugates: A new approach for targeting prostate cancer cells. Cancer Res 64:7668–7672.
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Khademhosseini A, Jon S, Hermmann A, Cheng J, Chin C, Kiselyuk A, Teply B, Eng G, Langer R. 2005. Microfluidic system for studying the interaction of nanoparticles and microparticles with cells. Anal Chem 77:5453–5459.
   PubMed Web of Science ®Google Scholar
• Ferapontova EE, Gothelf KV. 2009. Effect of serum on an RNA aptamer-based electrochemical sensor for theophylline. Langmuir 25:4279–4283.
   Google Scholar
• Freeman Rea. 2009. Self assembly of superamolecular aptamer structures for optical or electrochemical sensing. Analyst 134:653–656.
   Google Scholar
• Gibbons JA, Kanwar RK, Kanwar JR. 2011. Lactoferrin and cancer in different cancer models. Front Biosci (Schol Ed) 3:1080–1088.
   PubMedGoogle Scholar
• Goldstein NI, Prewett M, Zuklys K, Rockwell P, Mendelsohn J. 1995. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin Cancer Res 1:1311–1318.
   PubMed Web of Science ®Google Scholar
• Green LS, Jellinek D, Bell C, Beebe LA, Feistner BD, Gill SC, Jucker FM, Janjic N. 1995. Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. Chem Biol 2:683–695.
   PubMed Web of Science ®Google Scholar
• GU F et al. 2008. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. PNAS 105:2586–2591.
   PubMed Web of Science ®Google Scholar
• Haller AA, Sarnow P. 1997. In vitro selection of a 7-methyl-guanosine binding RNA that inhibits translation of capped mRNA molecules. Proc Natl Acad Sci USA 94:8521–8526.
   PubMed Web of Science ®Google Scholar
• Heckel A, Buff MC, Raddatz MS, Müller J, Pötzsch B, Mayer G. 2006. An anticoagulant with light-triggered antidote activity. Angew Chem Int Ed Engl 45:6748–6750.
   PubMed Web of Science ®Google Scholar
• Held DM, Kissel JD, Saran D, Michalowski D, Burke DH. 2006. Differential susceptibility of HIV-1 reverse transcriptase to inhibition by RNA aptamers in enzymatic reactions monitoring specific steps during genome replication. J Biol Chem 281:25712–25722.
   PubMed Web of Science ®Google Scholar
• Hernandez FJ, Kalra N, Wengel J, Vester B. 2009. Aptamers as a model for functional evaluation of LNA and 2’-amino LNA. Bioorg Med Chem Lett 19:6585–6587.
   PubMedGoogle Scholar
• Hertoghs KM, Ellis JH, Catchpole IR. 2003. Use of locked nucleic acid oligonucleotides to add functionality to plasmid DNA. Nucleic Acids Res 31:5817–5830.
   Google Scholar
• Hicke BJ, Stephens AW. 2000. Escort aptamers: A delivery service for diagnosis and therapy. J Clin Invest 106:923–928.
   PubMed Web of Science ®Google Scholar
• Hillaireau H, Couvreur P. 2009. Nanocarriers’ entry into the cell: Relevance to drug delivery. Cell Mol Life Sci 66:2873–2896.
   PubMed Web of Science ®Google Scholar
• Holliger P, Hudson PJ. 2005. Engineered antibody fragments and the rise of single domains. Nat Biotechnol 23:1126–1136.
   PubMed Web of Science ®Google Scholar
• Homann M, Göringer HU. 1999. Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res 27:2006–2014.
   PubMed Web of Science ®Google Scholar
• Huertas CEM, Fessi H, Elaissari A. 2010. Polymer-based nanocapsules for drug delivery. International Journal of Pharmaceutics 383:113–142.
   Google Scholar
• Hwang DW et al. 2010. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. The Journal of Nuclear Medicine 51:98–105.
   PubMed Web of Science ®Google Scholar
• Jenison SGRD, Pardi A, Polisky B. 1994. High-resolution molecular discrimination by RNA. Science 263:1425–1429.
   PubMed Web of Science ®Google Scholar
• Jensen KB, Atkinson BL, Willis MC, Koch TH, Gold L. 1995. Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands. Proc Natl Acad Sci USA 92:12220–12224.
   PubMed Web of Science ®Google Scholar
• JO MCN, JU M, Cheung E, Nishijima K, Robinson GS, Adamis AP, Shima DT. 2006. Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol 168:2036–2053.
   PubMed Web of Science ®Google Scholar
• Justin PD et al. 2009. Systemic administration of optimized aptamer-sirna chimeras promotes regression of Psma-expressing tumours. Nat Biotechnol 27:839–849.
   Google Scholar
• Kanwar JR, Kamalapuram SK, Kanwar RK. 2010a. Targeting survivin in cancer: Patent review. Expert Opin Ther Pat 20:1723–1737.
   PubMed Web of Science ®Google Scholar
• Kanwar JR, Mahidhara G, Kanwar RK. 2010b. MicroRNA in human cancer and chronic inflammatory diseases. Front Biosci (Schol Ed) 2:1113–1126.
   Google Scholar
• Kanwar JR, Mohan RR, Kanwar RK, Roy K, Bawa R. 2010c. Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases. Nanomedicine (Lond) 5:1435–1445.
   PubMed Web of Science ®Google Scholar
• Kanwar JR, Palmano KP, Sun X, Kanwar RK, Gupta R, Haggarty N, Rowan A, Ram S, Krissansen GW. 2008. ‘Iron-saturated’ lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy. Immunol Cell Biol 86:277–288.
   PubMed Web of Science ®Google Scholar
• Kanwar JR, Shen WP, Kanwar RK, Berg RW, Krissansen GW. 2001. Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy. J Natl Cancer Inst 93:1541–1552.
   PubMed Web of Science ®Google Scholar
• Kanwar JR, Singh N, Kanwar RK. 2011. Role of nanomedicine in reversing drug resistance mediated by ATP binding cassette transporters and P-glycoprotein in melanoma. Nanomedicine (Lond) 6:701–714.
   Google Scholar
• Kanwar RK, Cheung CH, Chang JY, Kanwar JR. 2010. Recent advances in anti-survivin treatments for cancer. Curr Med Chem 17:1509–1515.
   PubMedGoogle Scholar
• Kanwar RK, Kanwar JR. 2011. Immunomodulatory lactoferrin in the regulation of apoptosis modulatory proteins in cancer. Protein & Peptide Letters. Accepted on 05-08-2011.
   Google Scholar
• Kasahara Y, Kitadume S, Morihiro K, Kuwahara M, Ozaki H, Sawai H, Imanishi T, Obika S. 2010. Effect of 3’-end capping of aptamer with various 2’,4’-bridged nucleotides: Enzymatic post-modification toward a practical use of polyclonal aptamers. Bioorg Med Chem Lett 20:1626–1629.
   PubMed Web of Science ®Google Scholar
• Katoh Y, Katoh M. 2008. Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review). Int J Mol Med 22:271–275.
   PubMed Web of Science ®Google Scholar
• Kawata E, Ashihara E, Nakagawa Y, Kiuchi T, Ogura M, Yao H, Sakai K, Tanaka R, Nagao R, Yokota A, Takeuchi M, Kimura S, Hirai H, Maekawa T. 2010. A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro. Cancer Lett 294:245–253.
   Google Scholar
• Keefe AD, Cload ST. 2008. SELEX with modified nucleotides. Curr Opin Chem Biol 12:448–456.
   PubMed Web of Science ®Google Scholar
• Khaled A, Guo S, Li F, Guo P. 2005. Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology. Nano Lett 5:1797–1808.
   PubMed Web of Science ®Google Scholar
• Kim E, Jung Y, Choi H, Yang J, Suh JS, Huh YM, Kim K, Haam S. 2010. Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex. Biomaterials 31:4592–4599.
   PubMed Web of Science ®Google Scholar
• Kirkham M, Parton RG. 2005. Clathrin-independent endocytosis: New insights into caveolae and non-caveolar lipid raft carriers. Biochim Biophys Acta 1745:273–286.
   PubMed Web of Science ®Google Scholar
• Krissansen GW, Singh J, Kanwar RK, Chan YC, Leung E, Lehnert KB, Kanwar JR, Yang Y. 2006. A pseudosymmetric cell adhesion regulatory domain in the beta7 tail of the integrin alpha4beta7 that interacts with focal adhesion kinase and src. Eur J Immunol 36:2203–2214.
   Google Scholar
• Kusser W. 2000. Chemically modified nucleic acid aptamers for in vitro selections: Evolving evolution. J Biotechnol 74:27–38.
   PubMedGoogle Scholar
• Laity JH, Lee BM, Wright PE. 2001. Zinc finger proteins: New insights into structural and functional diversity. Curr Opin Struct Biol 11:39–46.
   PubMed Web of Science ®Google Scholar
• Lebars I, Richard T, Di Primo C, Toulmé JJ. 2007. LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1. Blood Cells Mol Dis 38:204–209.
   PubMed Web of Science ®Google Scholar
• Li, W, Yang, X, Wang, K, Tan, W, He, Y, Guo, Q, Tang, H, Liu, J. 2008. Real-time imaging of protein internalization using aptamer conjugates. Anal Chem 80:5002–8.
   PubMed Web of Science ®Google Scholar
• Lin L, Fu Q, Williams BA, Azzaz AM, Shogren-Knaak MA, Chaput JC, Lindsay S. 2009. Recognition imaging of acetylated chromatin using a DNA aptamer. Biophys J 97:1804–1807.
   PubMed Web of Science ®Google Scholar
• Lin Y, Nieuwlandt D, Magallanez A, Feistner B, Jayasena SD. 1996. High-affinity and specific recognition of human thyroid stimulating hormone (hTSH) by in vitro-selected 2’-amino-modified RNA. Nucleic Acids Res 24:3407–3414.
   PubMed Web of Science ®Google Scholar
• Lu D, Searles MA, Klug A. 2003. Crystal structure of a zinc-finger-RNA complex reveals two modes of molecular recognition. Nature 426:96–100.
   PubMedGoogle Scholar
• Lundberg P, El-Andaloussi S, Sütlü T, Johansson H, Langel U. 2007. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J 21:2664–2671.
   PubMed Web of Science ®Google Scholar
• Lünse CE, Michlewski G, Hopp CS, Rentmeister A, Cáceres JF, Famulok M, Mayer G. 2010. An aptamer targeting the apical-loop domain modulates pri-miRNA processing. Angew Chem Int Ed Engl 49:4674–4677.
   Google Scholar
• Majumder, P, Gomes, KN, Ulrich, H. 2009. Aptamers: from bench side research towards patented molecules with therapeutic applications. Expert Opin Ther Pat 19:1603–13.
   PubMed Web of Science ®Google Scholar
• Mathews L, Kanwar RK, Zhou S, Punj V, Kanwar JR. 2010. Applications of nanomedicine in antibacterial medical therapeutics and diagnostics. The Open Tropical Medicine Journal 3:1–9.
   Google Scholar
• Mayer G, Kröck L, Mikat V, Engeser M, Heckel A. 2005. Light-induced formation of G-quadruplex DNA secondary structures. Chembiochem 6:1966–1970.
   PubMed Web of Science ®Google Scholar
• McNamara JO 2nd, Andrechek ER, Wang Y, Viles KD, Rempel RE, Gilboa E, Sullenger BA, Giangrande PH. 2006. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol 24:1005–1015.
   PubMed Web of Science ®Google Scholar
• Mendonsa SD, Bowser MT. 2004. In vitro evolution of functional DNA using capillary electrophoresis. J Am Chem Soc 126:20–21.
   PubMed Web of Science ®Google Scholar
• Miyachi Y, Shimizu N, Ogino C, Kondo A. 2010. Selection of DNA aptamers using atomic force microscopy. Nucleic Acids Res 38:e21.
   PubMed Web of Science ®Google Scholar
• Miyake Y, Togashi H, Tashiro M, Yamaguchi H, Oda S, Kudo M, Tanaka Y, Kondo Y, Sawa R, Fujimoto T, Machinami T, Ono A. 2006. MercuryII-mediated formation of thymine-HgII-thymine base pairs in DNA duplexes. J Am Chem Soc 128:2172–2173.
   PubMed Web of Science ®Google Scholar
• Molpeceres J, Chacón M, Guzmán M, Berges L, del Rosario Aberturas M. 1999. A polycaprolactone nanoparticle formulation of cyclosporin-A improves the prediction of area under the curve using a limited sampling strategy. Int J Pharm 187:101–113.
   PubMed Web of Science ®Google Scholar
• Morris MC, Vidal P, Chaloin L, Heitz F, Divita G. 1997. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res 25:2730–2736.
   PubMed Web of Science ®Google Scholar
• Morris MC, Depollier J, Mery J, Heitz F, Divita G. 2001. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 19:1173–1176.
   PubMed Web of Science ®Google Scholar
• NG EWM, Calias P, Cunningham ETJR, Guyer DR, Adamis AP. 2006. Pegaptanib, a targeted anti-Vegf aptamer for ocular vascular disease. Nature Reviews 5:123–132.
   Web of Science ®Google Scholar
• Nutiu R, Li Y. 2005. Aptamers with fluorescence-signaling properties. Methods 37:16–25.
   PubMed Web of Science ®Google Scholar
• Ohk SH, Koo OK, Sen T, Yamamoto CM, Bhunia AK. 2010. Antibody-aptamer functionalized fibre-optic biosensor for specific detection of Listeria monocytogenes from food. J Appl Microbiol 109:808–817.
   PubMed Web of Science ®Google Scholar
• Orum H, Wengel J. 2001. Locked nucleic acids: A promising molecular family for gene-function analysis and antisense drug development. Curr Opin Mol Ther 3:239–243.
   Google Scholar
• Pastor F, Kolonias D, Giangrande PH, Gilboa E. 2010. Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay. Nature 465:227–230.
   PubMedGoogle Scholar
• Perret E, Lakkaraju A, Deborde S, Schreiner R, Rodriguez-Boulan E. 2005. Evolving endosomes: How many varieties and why? Curr Opin Cell Biol 17:423–434.
   PubMed Web of Science ®Google Scholar
• Petersen M, Wengel J. 2003. LNA: A versatile tool for therapeutics and genomics. Trends Biotechnol 21:74–81.
   PubMed Web of Science ®Google Scholar
• Qian J, Lou X, Zhang Y, Xiao Y, Soh HT. 2009. Generation of highly specific aptamers via micromagnetic selection. Anal Chem 81:5490–5495.
   PubMed Web of Science ®Google Scholar
• Riechmann L, Clark M, Waldmann H, Winter G. 1988. Reshaping human antibodies for therapy. Nature 332:323–327.
   PubMed Web of Science ®Google Scholar
• Ruckman J, Green LS, Beeson J, Waugh S, Gillette WL, Henninger DD, Claesson-Welsh L, Janjic N. 1998. 2’-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem 273:20556–20567.
   PubMed Web of Science ®Google Scholar
• Russell SJ, Llewelyn MB, Hawkins RE. 1992. The human antibody library. BMJ 304:585–586.
   Google Scholar
• Sampson T. 2003. Aptamers and Selex: The technology. World Patent Information 25:123–129.
   Google Scholar
• Seferos DS, Giljohann DA, Rosi NL, Mirkin CA. 2007. Locked nucleic acid-nanoparticle conjugates. Chembiochem 8:1230–1232.
   Google Scholar
• Sengle G, Jenne A, Arora PS, Seelig B, Nowick JS, Jäschke A, Famulok M. 2000. Synthesis, incorporation efficiency, and stability of disulfide bridged functional groups at RNA 5’-ends. Bioorg Med Chem 8:1317–1329.
   PubMedGoogle Scholar
• Shangguan D, Li Y, Tang Z, Cao ZC, Chen HW, Mallikaratchy P, Sefah K, Yang CJ, Tan W. 2006. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA 103:11838–11843.
   PubMed Web of Science ®Google Scholar
• Shaw BR, Moussa L, Sharaf M, Cheek M, Dobrikov M. 2008. Boranophosphate siRNA-aptamer chimeras for tumor-specific downregulation of cancer receptors and modulators. Nucleic Acids Symp Ser (Oxf) 53:655–656.
   Google Scholar
• Shen Y, Jin E, Zhang B, Murphy CJ, Sui M, Zhao J, Wang J, Tang J, Fan M, Van Kirk E, Murdoch WJ. 2010. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J Am Chem Soc 132:4259–4265.
   PubMed Web of Science ®Google Scholar
• Su S, Nutiu R, Filipe CD, Li Y, Pelton R. 2007. Adsorption and covalent coupling of ATP-binding DNA aptamers onto cellulose. Langmuir 23:1300–1302.
   PubMed Web of Science ®Google Scholar
• Shigdar S, Lin J, Yu Y, Pastuovic M, Wei M, Duan W. 2011. RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule. Cancer Sci 102:991–998.
   PubMed Web of Science ®Google Scholar
• Silahtaroglu A, Stenvang J. 2010. MicroRNAs, epigenetics and disease. Essays Biochem 48:165–185.
   Google Scholar
• Smirnov I, Shafer RH. 2000. Lead is unusually effective in sequence-specific folding of DNA. J Mol Biol 296:1–5.
   PubMed Web of Science ®Google Scholar
• Song E, Zhu P, Lee SK, Chowdhury D, Kussman S, Dykxhoorn DM, Feng Y, Palliser D, Weiner DB, Shankar P, Marasco WA, Lieberman J. 2005. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 23:709–717.
   PubMed Web of Science ®Google Scholar
• Sooter LJ, Riedel T, Davidson EA, Levy M, Cox JC, Ellington AD. 2001. Toward automated nucleic acid enzyme selection. Biol Chem 382:1327–1334.
   PubMed Web of Science ®Google Scholar
• Soundararajan S, Chen W, Spicer EK, Courtenay-Luck N, Fernandes DJ. 2008. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res 68:2358–2365.
   PubMed Web of Science ®Google Scholar
• Stenmark H, Olkkonen VM. 2001. The Rab GTPase family. Genome Biol 2:REVIEWS3007.
   PubMed Web of Science ®Google Scholar
• Stuart RK, Stockerl-Goldstein K, Cooper M, Devetten M, Herzig R, Medeiros B, Schiller G, Wei A, Acton G, Rizzieri D. 2009. Randomized phase II trial of the nucleolin targeting aptamer AS1411 combined with high-dose cytarabine in relapsed/refractory acute myeloid leukemia (Aml). J Clin Oncol 27:7019.
   Web of Science ®Google Scholar
• Sullenger BA, Gallardo HF, Ungers GE, Gilboa E. 1990. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63:601–608.
   PubMed Web of Science ®Google Scholar
• Tong R, Yala L, Fan TM, Cheng J. 2010. The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cells. Biomaterials 31:3043–3053.
   PubMed Web of Science ®Google Scholar
• Tsimikas S, Willerson JT, Ridker PM. 2006. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 47:C19–C31.
   Google Scholar
• Tuerk C, Gold L. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505–510.
   PubMed Web of Science ®Google Scholar
• Ulrich H, Magdesian MH, Alves MJ, Colli W. 2002. In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion. J Biol Chem 277:20756–20762.
   PubMed Web of Science ®Google Scholar
• Van der Goot FG, Gruenberg J. 2006. Intra-endosomal membrane traffic. Trends Cell Biol 16:514–521.
   PubMed Web of Science ®Google Scholar
• Vater A, Jarosch F, Buchner K, Klussmann S. 2003. Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: Tailored-SELEX. Nucleic Acids Res 31:1–7.
   Google Scholar
• Wagner-Whyte JKS, Preiss J, Kurz JC, Olson K, Hatala P, Boomer RM, Fraone JM, Brosnan N, Makim A et al. 2007. Discovery of a potent, direct thrombin inhibiting aptamer. J Thromb Haemost (Isth Congress abstracts).
   Google Scholar
• Wang AZ, Bagalkot V, Vasilliou CC, Gu F, Alexis F, Zhang L, Shaikh M, Yuet K, Cima MJ, Langer R, Kantoff PW, Bander NH, Jon S, Farokhzad OC. 2008. Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. ChemMedChem 3:1311–1315.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang M, Yang G, Zhang D, Ding H, Wang H, Fan M, Shen B, Shao N. 2003. Single-stranded DNA aptamers that bind differentiated but not parental cells: Subtractive systematic evolution of ligands by exponential enrichment. J Biotechnol 102:15–22.
   PubMed Web of Science ®Google Scholar
• Wang, W, ling-yun, J. 2009. Progress in aptamer screening methods. Chin J Anal Chem 37:454–460.
   Web of Science ®Google Scholar
• Wang Y, Pu KY, Liu B. 2010a. Anionic conjugated polymer with aptamer-functionalized silica nanoparticle for label-free naked-eye detection of lysozyme in protein mixtures. Langmuir 26:10025–10030.
   Google Scholar
• Wang Z, Ho PC. 2010b. A nanocapsular combinatorial sequential drug delivery system for antiangiogenesis and anticancer activities. Biomaterials 31:7115–7123.
   PubMed Web of Science ®Google Scholar
• Weiss TC, Zhai GG, Bhatia SS, Romaniuk PJ. 2010. An RNA aptamer with high affinity and broad specificity for zinc finger proteins. Biochemistry 49:2732–2740.
   Google Scholar
• White R, Rusconi C, Scardino E, Wolberg A, Lawson J, Hoffman M, Sullenger B. 2001. Generation of species cross-reactive aptamers using “toggle” SELEX. Mol Ther 4:567–573.
   PubMed Web of Science ®Google Scholar
• Wlotzka B, Leva S, Eschgfäller B, Burmeister J, Kleinjung F, Kaduk C, Muhn P, Hess-Stumpp H, Klussmann S. 2002. In vivo properties of an anti-GnRH Spiegelmer: An example of an oligonucleotide-based therapeutic substance class. Proc Natl Acad Sci USA 99:8898–8902.
   PubMed Web of Science ®Google Scholar
• Wolfgang, P, Tasset, D, Janic, N, Gold, L, Kirschenheuter, GP. 1997. High affinity nucleic acid ligand containing modified nucleotides. US Patent No 5:660–985.
   Google Scholar
• Woodrow, KA, Cu, Y, Booth, CJ, Saucier-Sawyer, JK, Wood, MJ, Saltzman, WM. 2009. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat Mater 8:526–33.
   PubMed Web of Science ®Google Scholar
• Wu L, Curran JF. 1999. An allosteric synthetic DNA. Nucleic Acids Res 27:1512–1516.
   PubMed Web of Science ®Google Scholar
• Xie J, Chen K, Huang J, Lee S, Wang J, Gao J, Li X, Chen X. 2010. PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials 31:3016–3022.
   PubMed Web of Science ®Google Scholar
• XU W, LU Y. 2010. Label-Free Fluorescent Aptamer Sensor Based on Regulation of Malachite Green Fluorescence. Anal Chem 82:574–578.
   PubMed Web of Science ®Google Scholar
• Xua Z, Takanori T, Riordana JF., and HU GF. 2002. The nuclear function of angiogenin in endothelial cells is related to rrna production. Biochemical and Biophysical Research Communications 294:287–292.
   Google Scholar
• Yang X, Bassett SE, Li X, Luxon BA, Herzog NK, Shope RE, Aronson J, Prow TW, Leary JF, Kirby R, Ellington AD, Gorenstein DG. 2002a. Construction and selection of bead-bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing. Nucleic Acids Res 30:e132.
   PubMed Web of Science ®Google Scholar
• Yang X, Bassette SE, LI X, Luxon BA, Herzog NK, Shope RE, Aronson J, Prow TW, Leary JF, Kirby R, Ellington AD, Gorenstein DG. 2002b. Construction and selection of bead-bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries designed for rapid Pcr-based sequencing. Nucleic Acids Res 30:1–8.
   PubMedGoogle Scholar
• Yang, X, Li, N, Gorenstein, DG. 2011. Strategies for the discovery of therapeutic aptamers. Expert Opinion on Drug Discovery 6:75–87.
   PubMed Web of Science ®Google Scholar
• Zhang CY, Johnson LW. 2009. Single quantum-dot-based aptameric nanosensor for cocaine. Anal Chem 81:3051–3055.
   PubMed Web of Science ®Google Scholar
• Zhou J, LI H, Zhang J, Piotr S, Rossi J. 2011. Development of cell-type specific anti-Hiv gp120 aptamers for sirna delivery. J Vis Exp 23:pii: 2954.
   Google Scholar
• Zhou J, Li H, Li S, Zaia J, Rossi JJ. 2008. Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy. Mol Ther 16:1481–1489.
   PubMed Web of Science ®Google Scholar
• Zhou J, Rossi JJ. 2010. Aptamer-targeted cell-specific RNA interference. Silence 1:4.
   PubMedGoogle Scholar